Cevoglitazar, a novel peroxisome proliferator-activated receptor-alpha/gamma dual agonist, potently reduces food intake and body weight in obese mice and cynomolgus monkeys.

MLA

Chen, Hong, et al. “Cevoglitazar, a Novel Peroxisome Proliferator-Activated Receptor-Alpha/Gamma Dual Agonist, Potently Reduces Food Intake and Body Weight in Obese Mice and Cynomolgus Monkeys.” Endocrinology, vol. 151, no. 7, July 2010, pp. 3115–24. EBSCOhost, https://doi.org/10.1210/en.2009-1366.

APA

Chen, H., Dardik, B., Qiu, L., Ren, X., Caplan, S. L., Burkey, B., Boettcher, B. R., & Gromada, J. (2010). Cevoglitazar, a novel peroxisome proliferator-activated receptor-alpha/gamma dual agonist, potently reduces food intake and body weight in obese mice and cynomolgus monkeys. Endocrinology, 151(7), 3115–3124. https://doi.org/10.1210/en.2009-1366

Chicago

Chen, Hong, Beatriz Dardik, Ling Qiu, Xianglin Ren, Shari L Caplan, Bryan Burkey, Brian R Boettcher, and Jesper Gromada. 2010. “Cevoglitazar, a Novel Peroxisome Proliferator-Activated Receptor-Alpha/Gamma Dual Agonist, Potently Reduces Food Intake and Body Weight in Obese Mice and Cynomolgus Monkeys.” Endocrinology 151 (7): 3115–24. doi:10.1210/en.2009-1366.